Dr. Dave Singh's Presentation at London ENT Conference Met With Excitement from Peers

Wednesday, November 21, 2018 Press Release
Email Print This Page Comment bookmark
Font : A-A+

Conference Paper Showcases Treatment Success Utilizing Vivos Therapeutic System

DENVER, Nov. 20, 2018 /PRNewswire/ -- At a recent international ENT Conference in London, UK

Dr. Dave Singh, President and Chief Medical Officer of Vivos Therapeutics, presented pioneering findings regarding the long-term clinical implications of utilizing the Vivos System, garnering a very positive response from attendees. Vivos Therapeutics is a leading company focused on addressing the root causes of mild-to-moderate sleep apnea, advocating a non-surgical treatment as a potentially permanent solution.

The large, international audience consisted of renowned otolaryngologists—head and neck surgeons. Dr. Singh's paper, entitled Non-surgical improvement of the upper airway for sleep disordered breathing: 5 year follow up, described the treatment of a 56-year-old male patient diagnosed with sleep apnea. Treatment consisted of 18 months of using the Vivos Therapeutic System. In a 5.5-year follow-up after initial use of a Vivos System oral appliance, the upper airway volume was shown to have increased significantly and its cross-sectional area had also increased dramatically.  In other words, no relapse or regression in the size, shape, or function of the airway towards pre-treatment conditions was detected.

"The results of this particular case-study serve to further underline the results possible from utilizing the Vivos System of proprietary biomimetic oral appliances and corresponding protocols," said Dr. Singh. "From this, we conclude that the Vivos System may be able to non-surgically enhance the upper airway in adult patients diagnosed with sleep disordered breathing."

"In our mission to rid the world of the life-threatening condition known as obstructive sleep apnea, it is essential to reach the wide array of health care professionals involved in treating issues related to obstructive sleep apnea," said Vivos CEO Kirk Huntsman. "We look forward to continue to sharing research and results with doctors around the world."

ABOUT VIVOSHeadquartered in Denver Colorado, Vivos Therapeutics Inc. is a company that provides training for dentists and health care providers, allowing them to integrate breathing wellness into their practice. The Vivos System is a proprietary, non-invasive, non-surgical treatment protocol, administered by a multidisciplinary team of highly-trained health care professionals. This revolutionary technology represents the first hope for a lasting solution to the problem of sleep apnea. Vivos Therapeutics has over 850 Certified and Integrated Providers throughout the US and two Canadian Provinces. For more information, please visit https://www.vivoslife.com/.

Media Contact:Mollie WagonerLive Wire Media Relations, LLC(703) 519-1600 Ext. 106mwagoner@livewiredc.com

Cision View original content:http://www.prnewswire.com/news-releases/dr-dave-singhs-presentation-at-london-ent-conference-met-with-excitement-from-peers-300753883.html

SOURCE Vivos Therapeutics



Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Find a Doctor

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store